Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of HERBALIFE LTD. from 31 Dec 2022 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
- Summary
-
HERBALIFE LTD. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
- HERBALIFE LTD. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 31 Dec 2025 was $509,400,000, a 36% increase year-over-year.
- Source SEC data
- View on sec.gov
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)
HERBALIFE LTD. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $509,400,000 | +$291,700,000 | +36% | 31 Dec 2025 | 10-K | 18 Feb 2026 | 2025 | FY |
| Q3 2025 | $606,000,000 | +$348,200,000 | +36% | 30 Sep 2025 | 10-Q | 05 Nov 2025 | 2025 | Q3 |
| Q2 2025 | $654,400,000 | +$382,800,000 | +37% | 30 Jun 2025 | 10-Q | 05 Nov 2025 | 2025 | Q3 |
| Q1 2025 | $736,000,000 | +$300,600,000 | +29% | 31 Mar 2025 | 10-Q | 06 Aug 2025 | 2025 | Q2 |
| Q4 2024 | $801,100,000 | +$259,200,000 | +24% | 31 Dec 2024 | 10-K | 18 Feb 2026 | 2025 | FY |
| Q3 2024 | $954,200,000 | 30 Sep 2024 | 10-Q | 05 Nov 2025 | 2025 | Q3 | ||
| Q2 2024 | $1,037,200,000 | 30 Jun 2024 | 10-Q | 05 Nov 2025 | 2025 | Q3 | ||
| Q1 2024 | $1,036,600,000 | 31 Mar 2024 | 10-Q | 06 Aug 2025 | 2025 | Q2 | ||
| Q4 2023 | $1,060,300,000 | +$205,600,000 | +16% | 31 Dec 2023 | 10-K | 18 Feb 2026 | 2025 | FY |
| Q4 2022 | $1,265,900,000 | 31 Dec 2022 | 10-K | 18 Feb 2026 | 2025 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.